ITRM vs USB
Iterum Therapeutics PLC (ITRM) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
ITRM currently screens at market cap $38.6M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the ITRM and USB stock pages for the full models.
Not investment advice.